Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines

In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through another busy two-week period in the field, including:Oregon Health Authority’s decision to shelve its proposed doubling of fees levied on state-regulated psilocybin entities (ft. Taylor West, Exec. Director, Healing Advocacy)California carves out $4.7M for psychedelic researchThe DEA again moves to schedule 5 tryptaminesThe PATH Caucus publishes its RFI white paperStanford and UCSF researchers call for “more aggressive” blinding in psychedelic trials (ft. Joshua Woolley, UCSF)Read more:Psychedelic Bulletin 232: Oregon Backpedals Psilocybin Fee Hike; DEA Again Moves to Schedule 5 TryptaminesThe Psychedelic News Feed is published by Psychedelic Alpha and airs every two weeks.This episode of The Psychedelic News Feed is supported by UBC. As psychedelic therapies move toward potential approvals, UBC helps sponsors navigate the evidence generation, pharmacovigilance, and comprehensive risk management strategies that support a path forward grounded in patient safety. Learn more at ubc.com.Send us your questions and comments at pod@psychedelicalpha.com Read more and join our newsletter at https://psychedelicalpha.comFollow us on Instagram @psychedelicalpha, X @Psyched_Alpha, and LinkedIn.Subscribe to Pα+ for premium insights: https://psychedelicalpha.com/join/